tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Parkes, 3 are a BUY (60%), 1 are a HOLD (20%), 1 are a SELL (20%).
Analyst Richard Parkes, currently employed at BNP, carries an average stock price target met ratio of 100% that have a potential upside of 22.41% achieved within 306 days.
Richard Parkes’s has documented 9 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 02-Dec-2024.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 6/27/2022. The price target of $52.88 was fulfilled within 1 day with a profit of $0.48 (0.9%) receiving and performance score of 9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Apr-2019
$105
$-78.6 (-42.81%)
$95
3 months 13 days ago
(09-Dec-2025)
0/13 (0%)
$-74.1 (-41.37%)
Buy Since 05-Sep-2023
$108.5
$-75.1 (-40.90%)
$88
3 months 25 days ago
(25-Nov-2025)
1/5 (20%)
$-79.22 (-42.20%)
482
Buy Since 12-Jul-2023
4 months 23 days ago
(27-Oct-2025)
6/6 (100%)
$12.74 (9.80%)
216
Buy Since 27-Jan-2020
$87
$-96.6 (-52.61%)
$78
1 years 4 months 4 days ago
(18-Nov-2024)
0/9 (0%)
$-34.46 (-28.37%)
Buy Since 05-Jan-2023
$88
$-95.6 (-52.07%)
$89
1 years 4 months 9 days ago
(13-Nov-2024)
0/7 (0%)
$-37.08 (-29.65%)
What Year was the first public recommendation made by Richard Parkes?
